TIFFANY WIMSATT: Open Payments
NPI 1851657241 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 77 payments from 19 companies in 2025. Trend: 2023 $3,424 · 2024 $2,239 · 2025 $1,490
Food & beverage: $1,421Education: $69
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $468 |
| Janssen Biotech, Inc. | 5 | $181 |
| ABBVIE INC. | 10 | $135 |
| Galderma Laboratories, L.P. | 3 | $82 |
| LEO Pharma Inc. | 3 | $79 |
| UCB, Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Amgen Inc. | 3 | $59 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $55 |
| PFIZER INC. | 3 | $53 |
Products named: COSENTYX, TREMFYA, SKYRIZI, NEMLUVIO, Bimzelx, Sotyktu, OTEZLA, CIBINQO.
Industry payments across AL — which companies pay providers there.
